DISEASE INDICATIONS: Spinal Muscular Atrophy

MANUFACTURER: Biogen Idec Ltd

USAGE: Intrathecal Injection

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Spinraza (Nusinersen) is an intrathecal injection used to treat Spinal Muscular Atrophy (SMA) by increasing the production of the SMN protein, promoting the survival and health of motor neurons; this promotes improved muscle control and movement.